Fibtacular is bridging the key materials gap in drug discovery and regenerative medicine. While 90% of drugs fail in human trials due to non-predictive models, our team of innovators from Harvard, Georgia Tech, and Notre Dame has developed a proprietary additive manufacturing platform to solve this bottleneck. We manufacture programmable, nanofibrous 3D scaffolds that mimic human tissue architecture, significantly expanding the standard industry lifespan of human tissue cultures. By combining deep-tech expertise from Impossible Foods, Beyond Meat, and the Air Force Research Lab, we are scaling the architectural foundations necessary to make predictive drug testing a reality.
